Using a predetermined formula, the ONS Board of Directors annually evaluates membership dues to ensure the levels will enable the Society to continue to provide ONS members with the high-quality products, services, and resources they need to transform care for patients with cancer. Based on the formula, the Board decided to maintain dues at the 2019 level for 2020.

ONS wrapped up the first four months of 2019 as a financially strong organization, according to the finance reports the ONS Board of Directors received during its June 13–15 meeting. The Society’s investments are up almost 9%. It also saw an increase in ONS Congress revenue from 2018 to 2019 and will not raise Congress registration fees for 2020. A solid financial outlook allows ONS to continue to serve its members by representing and growing the profession. 
 

On Sunday, April 14, 2019, the ONS Board of Directors held a face-to-face meeting at the end of a highly successful ONS 44th Annual Congress in Anaheim, CA. New directors took office and new plans unfolded for fostering nurse leaders and supporting ONS chapters.

Cancer care is evolving rapidly, and ONS is committed to providing oncology nurses with tools to stay abreast of innovative treatments and technologies used to care for people with cancer. The ONS Board of Directors has both strategic and stewardship responsibilities for the fiscal health of the organization that will help us to meet those goals. 

It was a full agenda for the ONS Board of Directors’ February 2019 in-person meeting, during which critical discussions and decisions about ONS and oncology nursing occurred.   

Setting ONS up for a strong future was the overarching theme of the January 2019 ONS Board of Directors meeting by conference call. The group appointed new members to the Leadership Development Committee—which grows, shapes, and nominates ONS’s future leaders—and devised a strategy for identifying what oncology nursing’s role will be 10 years in the future.  

During its December 2018 meeting, the ONS Board of Directors closed a successful year with discussions and decisions that will strengthen ONS leadership at all levels in 2019 and beyond.

During the October 2018 board meeting held at the national office, the ONS Board of Directors heard reports from leadership and status reports on research and evidence-based practice work, discussed key initiatives, received an update from the Oncology Nursing Foundation, and reviewed and approved the Society’s operating budget for 2019. Additionally, two key generative discussions focused on the ongoing implementation of ONS chapter model changes and a review and strategy session around ONS position statements.

During the ONS Board of Directors monthly meeting by conference call in September 2018, supporting ONS chapters through the model transition continued to top the agenda.

ONS chapters, endorsed recommendations and guidelines, and the role of nurses caring for patients with cancer topped the ONS Board of Directors’ discussion topics during its August 2018 conference call meeting.

Discussion of ONS’s financial health was a key item on the agenda for the July 2018 Board of Directors meeting. As one of the quarterly face-to-face meetings the Board holds in conjunction with ONS Leadership Weekend, the meeting also provided the opportunity for in-depth discussion around several additional topics.

Look for some new changes related to ONS Board of Directors activities during the 44th Annual ONS Congress in Anaheim, CA, in April 2019. During its June 2018 meeting, the Board discussed and made decisions about two Congress-related topics: the annual business meeting and the inclusion of leadership awareness. 

As the ONS Board of Directors held its first meeting with some of its newest members after the 43rd Annual ONS Congress in May, transitions were top of mind. The Board successfully transitioned its leadership as new president, Laura Fennimore, DNP, RN, NEA-BC, and three new directors-at-large (Heather Thompson Mackey, MSN, RN, ANP-BC, AOCN^®, Anne Ireland, MSN, RN, AOCN^®, CENP, and Susan Bruce, MSN, RN, OCN^®, AOCNS^®) came on board.

To meet the ONS mission as well as 501(c)(6) organization requirements, ONS’s key categories of revenue and expenses continue to focus on providing member and educational services, such as website resources, online and journal-related continuing nursing education, and publications that support oncology nurses and quality patient care.

To save costs and reduce the number of meetings, the ONS Board combined the traditional January and March meetings into a late-February meeting. It served as my final in-person board meeting, a bittersweet moment filled with reflection on ONS’s past, present, and future. 

On its January conference call, the ONS Board of Directors completed work that will guide ONS leadership for the future.

At the October Board meeting, we looked back at 2017 as a year that included great meeting times for ONS members at Congress in Denver, CO; regional chapter officer meetings; Leadership Weekend in Pittsburgh, PA; and Capitol Hill Days in Washington, DC. The ONS Board also looked ahead to 2018 and the third year of the strategic plan.

Laura Fennimore, DNP, RN, NEA-BC, professor of acute and tertiary care at the University of Pittsburgh School of Nursing in Pittsburgh, PA, has been selected as the next ONS president for the 2018–2020 term. She will be president-elect effective January 1, 2018. Fennimore’s appointment is the first under the ONS bylaw changes that were voted into practice by members in 2016. These governance changes provide the ONS Board of Directors the authority to select candidates from among the member-elected directors-at-large to fill officer roles on the ONS Board.

In 2017, the ONS Board is implementing the new process where the Board of Directors appoints the next president who will be responsible for the ongoing shaping and molding of our society. During our virtual meeting on August 29, this was one of the most important topics that we discussed. The Board is committed to ensuring that our next leader has the vested interest of our organization and possesses the core competencies and values necessary to continue to move our organization forward.

The annual ONS Leadership Weekend brings together the boards of ONS, ONS Foundation (ONSF), and the Oncology Nursing Certification Corporation (ONCC); the ONS Leadership Development Committee; the ONCC committee chairs; and leadership representatives from all of our chapters. Many national office staff join in the planning and activities too. The weekend is a valued, traditional investment in volunteer leaders at the local and national levels. In one session during this year’s meeting in July 2017, the questions that were asked indicated to me that understanding ONS and the roles and responsibilities of the various groups in the ONS enterprise could be helpful.

The ONS budgeting cycle is not unlike what occurs annually at each of our healthcare settings. ONS staff and senior leadership work to develop a budget each year. In March 2017, the ONS Board of Directors met with staff to review the year-end financials for 2016. This review helps us prepare for the treasurer’s presentation during the Business Meeting at the 42nd Annual ONS Congress in Denver in May.  We will meet again in September and October to review and approve the proposed budget for 2018.

Two years ago, I became ONS’s third chief executive officer and the staff partner to a Board of Directors that had a clear vision for a system that marches. If, as a member, you feel that ONS has undergone many changes in the past two years, you are correct.

One of the ONS Board of Directors’ goals is to increase your familiarity with us and what we are currently working on for the Society. In July we met with more than 400 other ONS leaders in Pittsburgh for Leadership Weekend. Board members from the Oncology Nursing Certification Corporation, ONS Foundation, and Leadership Development Council were included, as well as community and chapter leaders. It was an exciting weekend with a lot of enthusiastic and energized leaders.